Advise the patient to inform the doctor or pharmacist if the patient is taking, has recently taken or might take any other medicines.
Especially if the patient is taking any of the following medicines: Certain antidepressants (selective serotonin reuptake inhibitors, selective serotonin-norepinephrine reuptake inhibitors, tricyclic or tetracyclic antidepressants); the antibiotic ciprofloxacin used against infections; the cough suppressant dextromethorphan; sympathomimetics such as those present in eye drops, nasal and oral decongestants and cold medicine containing ephedrine or pseudoephedrine.
The use of Rasagiline Genepharm together with the antidepressants containing fluoxetine or fluvoxamine should be avoided.
If the patient is starting treatment with Rasagiline Genepharm, the patient should wait at least 5 weeks after stopping fluoxetine treatment.
If the patient is starting treatment with fluoxetine or fluvoxamine, the patient should wait at least 14 days after stopping Rasagiline Genepharm treatment.
Advise the patient to inform the doctor or pharmacist if the patient is smoking or intends to stop smoking. Smoking could decrease the amount of rasagiline in the blood.